{"id":"NCT01944098","sponsor":"University of South Florida","briefTitle":"Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients","officialTitle":"Systemic Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients: A Randomized, Placebo-Controlled Pilot Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08","primaryCompletion":"2014-07","completion":"2014-09","firstPosted":"2013-09-17","resultsPosted":"2017-10-26","lastUpdate":"2017-10-26"},"enrollment":20,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Bariatric Surgical Pain"],"interventions":[{"type":"DRUG","name":"Lidocaine","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Lidocaine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective is to assess the feasibility and safety of administering continuous intraoperative lidocaine infusions in adult patients undergoing laparoscopic Roux en Y Gastric Bypass (RYGB). The secondary objective is to determine if lidocaine administration versus placebo (dextrose administration) (initiated at the time of anesthesia induction and continued until extubation) will reduce postoperative narcotic requirements.","primaryOutcome":{"measure":"Postoperative Pain","timeFrame":"6 hours post-surgery","effectByArm":[{"arm":"Lidocaine","deltaMin":3,"sd":null},{"arm":"Placebo","deltaMin":4.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":13},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":["Dizziness","Metallic Taste in Mouth","Significant Blood Pressure Changes"]}}